Accreditation Information

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Boston University School of Medicine and PERT Consortium. Boston University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Boston University School of Medicine designates this live activity for a maximum of 15 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This educational activity has been provided by  Boston University School of Medicine Continuing Nursing Education and jointly-provided by PERT Consortium.

Boston University School of Medicine Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.





The specific goals of this Annual Scientific Symposium are:


  • To educate the medical community on the latest advances in the diagnosis, risk stratification andtreatment of PE.
  • To explore the science behind PE diagnosis and treatment and share knowledge regarding PE prevention and management.
  • To identify and explore science of venous thromboembolic disease (VTE), the precursor to PE, and understand both prevention and treatment modalities for VTE.
  • To provide a forum for presentation of novel approaches to PE management, both acute and chronic.
  • To recognize the potential complications from PE and how to prevent and treat them.
  • To better understand the incidence, detection, and treatment of potential longā€term consequences of acute PE, such as chronic thromboembolic pulmonary hypertension (CTEPH) and chronic thromboembolic disease (CTED).
  • To understand coagulopathies and evaluate latest pharmacologic treatment options
  • To explore novel mechanical treatment modalities for thrombus resolution or removal
  • To highlight unique patient populations and their specific treatment challenges, including patients actively or previously infected with COVID-19.
  • To characterize the various manifestations and presentations of thrombosis and VTE seen with COVID-19 as well as the VITT syndrome
  • To define proper anticoagulation strategies for hospitalized and outpatient COVID-19 patients, both for patients with active or convalescent infection, and appropriate treatment/prophylaxis after discharge of COVID-19 patients
  • To promote and enhance multidisciplinary coordinated response to the care of PE patients.
  • To delineate the role of PERT in COVID-19 patient, including adjustments in the treatment paradigms necessitated by active infection
  • To explore opportunities for quality improvement in PE management.

Target Audience

This two day course is designed to educate practicing clinicians who diagnose and/or treat patients with pulmonary embolism; academics and scientists who study pulmonary embolism.



Faculty Disclosure

All planners, speakers, authors, and reviewers involved with content development for continuing education activities provided by Boston University are expected to disclose any real or perceived conflict of interest related to the content of the activity. Detailed disclosures will be included in participant materials or given prior to the start of the activity.